F2R Knockout SK-N-SH Cell Line

The choice depends on whether you are studying F2R (PAR1, protease-activated receptor 1)'s role as the principal thrombin receptor or modeling its functions in platelet aggregation and emerging roles in neural biology. The Knockout line is the standard tool for asking whether PAR1 is required for thrombin-induced signaling — F2R/PAR1 is the primary thrombin receptor activated by thrombin cleavage of the extracellular N-terminus (LDPR41/S42), exposing a tethered ligand (SFLLRN) that activates Gαq, Gα12/13, and Gi signaling; PAR1 is critical for platelet aggregation downstream of thrombin in hemostasis. Overexpression is useful for studying PAR1 gain-of-function effects. For neural research, the EDITGENE F2R Knockout in SK-N-SH is relevant — SK-N-SH is a neuroblastoma cell line, and PAR1 has been characterized as expressed in neural cells with emerging roles in neuroinflammation and neuroprotection following thrombin exposure (BBB disruption, hemorrhage). Rescue with wild-type or cleavage-resistant PAR1 (R41A) enables structure-function studies. The knockout is a critical specificity control for ⭐ vorapaxar (Zontivity, FDA-approved 2014 antiplatelet PAR1 antagonist for cardiovascular events post-MI), atopaxar, and emerging PAR1-targeted therapeutics.

Primary applications: • Thrombin-induced signaling: phospho-ERK, Ca²⁺ mobilization following thrombin stimulation in PAR1-null cells. • Vorapaxar specificity: critical genetic control for vorapaxar (Zontivity, FDA-approved antiplatelet PAR1 antagonist for cardiovascular events post-MI). • Neural PAR1 biology: in heterologous neural contexts, PAR1's emerging roles in neuroinflammation and BBB disruption following hemorrhage. • PAR family comparative studies: PAR2 (F2RL1), PAR3, PAR4 (F2RL3) expression analysis for family-wide protease-activated signaling. EDITGENE recommends this SK-N-SH-based model for researchers investigating PAR1 biology in neural contexts and emerging neuroprotection strategies.

Yes. PAR1 rescue experiments require attention to thrombin cleavage activation: • Construct design: use a codon-modified F2R sequence with a small intracellular C-terminal tag (FLAG, HA). PAR1 is a seven-transmembrane GPCR — preserve N-terminal extracellular tail with thrombin cleavage site (LDPR41/S42). • Cleavage-resistant rescue: R41A mutation in the thrombin cleavage site abolishes thrombin activation while preserving PAR1-AP (SFLLRN) responsiveness — enabling separation of biased activation modes. • Surface localization validation: confirm plasma membrane localization before functional assays. • Vorapaxar resistance studies: PAR1 mutations conferring vorapaxar resistance for on-target inhibitor validation. • Functional readout: rescue should restore thrombin-induced phospho-ERK and Ca²⁺ mobilization. SK-N-SH-specific considerations: • SK-N-SH is a human neuroblastoma cell line (parental line to the more widely used SH-SY5Y subclone) — used for neuronal biology and neuroblastoma research. • Lentiviral transduction is supported with moderate efficiency. • SK-N-SH exhibits both N-type (neuronal) and S-type (epithelial-like) morphology that can affect phenotypic analysis — characterize cellular subtype before phenotypic assays.